Myriad Genetics (MYGN) Debt Ratio (2016 - 2026)

Myriad Genetics has disclosed Debt Ratio across 10 years of filings, most recently posting 0.18 for Q1 2026.

• In Q1 2026, Debt Ratio rose 202.96% year-over-year to 0.18; the TTM figure through Mar 2026 stood at 0.18 (up 202.96% YoY), while the FY2025 annual figure was 0.17, up 340.33% from the prior year.
• Debt Ratio grew to 0.18 in Q1 2026, from 0.17 in the prior quarter.
• Over the last five years, Debt Ratio for MYGN reached as high as 0.18 in Q1 2026 and fell as low as 0.03 in Q2 2023.
• The 4-year median for Debt Ratio is 0.04 (2024), against an average of 0.08.
• Annual changes were most pronounced in 2024 — Debt Ratio increased 7.65% — and 2025, when it surged 355.05%.
• A 4-year view of Debt Ratio shows it stood at 0.03 in 2023, then gained by 14.76% to 0.04 in 2024, then jumped by 340.33% to 0.17 in 2025, then gained by 5.23% to 0.18 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.18, 0.17, and 0.16 for Q1 2026, Q4 2025, and Q3 2025 respectively.